Journal of Clinical Oncology
Articles in this Issue
Post-residency career intentions among oncology and related specialty residents in Armenia.
e21012 Background: In Armenia, postgraduate training for Medical, Radiation, and Surgical oncology is delivered through a...
Effect of an EHR-facilitated symptom surveillance intervention on rehabilitation utilization in cancer patients.
1587 Background: Rehabilitation services (physical medicine and rehabilitation [PM&R], physical therapy [PT], occupati...
Allostatic load and myosteatosis in women with metastatic breast cancer at diagnosis.
e13018 Background: llostatic load (AL), a measure of cumulative physiological stress, and myosteatosis, fatty infiltration...
Early versus delayed initiation of first-line immune checkpoint inhibitors in metastatic non–small cell lung cancer: A real-world analysis of treatment timing and care context.
e20660 Background: Immune checkpoint inhibitors (ICIs) are standard first-line therapy for metastatic non–small cell lung...
A machine learning algorithm for optimizing treatment selection for patients with up to three hepatocellular carcinomas measuring ≤ 3 cm.
4019 Background: Liver resection (LR) and radiofrequency ablation (RFA) are recommended for patients with early-stage hepa...
Phase II study evaluating ivonescimab in combination with chemotherapy as first- and second-line treatment of advanced or metastatic gastric and gastroesophageal adenocarcinoma patients (UCGI 52 – GRACIE).
TPS4239 Background: The prognosis of advanced/metastatic gastroesophageal adenocarcinomas (GEA) has recently improved with...
Impact of metformin on outcomes with immune checkpoint inhibitors in renal cell carcinoma: A large-scale retrospective analysis.
e16558 Background: Immune checkpoint inhibitors (ICIs) are a mainstay in the treatment of renal cell carcinoma (RCC). Metf...
A validation study of a novel biomarker-based scoring system (EAST score) for limited-stage small-cell lung cancer: A secondary analysis of JCOG0202 and JCOG1011.
8081 Background: Concurrent chemoradiotherapy (CCRT) followed by prophylactic cranial irradiation (PCI) is potentially cur...
SPARTO: A phase I study of PD-1 inhibitor spartalizumab (PDR001) in combination with low dose of pazopanib in pediatric relapsed/refractory tumors.
10001 Background: The initial results of immunotherapy in children with refractory/relapsed tumors have been disappointing...
Timing of palliative care referral and overall survival in patients with melanoma brain metastases treated with ipilimumab and nivolumab.
e21607 Background: The association between timing of palliative care referral and survival outcomes in patients with melan...
Plasma ISG15 as predictor of outcome from antiangiogenic therapy in solitary fibrous tumor: Analysis from the GEIS-69 trial.
e23520 Background: Solitary fibrous tumor (SFT) is a rare sarcoma subtype characterized by limited therapeutic options in...
Efficacy and safety of cadonilimab in patients with MSI-H/dMMR locally advanced or metastatic gastrointestinal malignancies: A real-world retrospective study.
2623 Background: Immunotherapies targeting PD-1 and CTLA-4 have emerged as promising therapeutic strategies for gastrointe...
Risk of developing brain/central nervous system (CNS) metastases across multiple <i>ERBB2</i> -altered cancer types: Genotype as shaper of phenotype.
2022 Background: ERBB2 (HER2) alterations are associated with increased risk of brain metastases in br...
High-quality 4D anatomical and functional MRI for abdominal tumor motion management.
e16013 Background: 4D-MRI offers superior soft-tissue contrast for abdominal motion management but is often limited by the...
Association between clonal plasma cell S-phase after autologous stem cell transplantation and survival outcomes in multiple myeloma.
e19564 Background: Risk stratification in multiple myeloma (MM) relies on baseline staging systems and cytogenetic abnorma...
Global variation in thromboprophylaxis models of care and implementation supports for hospitalized and ambulatory cancer care.
e13627 Background: Cancer-associated thrombosis (CAT) is a leading cause of morbidity and mortality. As systemic therapies...
Burden and temporal trends of pediatric central nervous system tumors in Kenya: A 15-year analysis from a national referral hospital.
e14045 Background: Pediatric central nervous system (CNS) tumors are a leading cause of childhood cancer mortality globall...
How long is long enough? Outcomes with finite-duration bispecific antibody therapy in multiple myeloma.
7538 Background: Bispecific antibodies (BsAbs) have shown unprecedented efficacy in relapsed/refractory multiple myeloma (...
Determinants of survival in 356 patients failing frontline HMA-Ven for newly-diagnosed AML.
e18524 Background: Venetoclax (Ven) in combination with hypomethylating agents (HMA) is FDA-approved front-line therapy fo...
First-line HLX07 vs placebo combined with serplulimab and chemotherapy for nasopharyngeal carcinoma: A randomized, double-blind, multicenter phase 2 study.
6042 Background: Programmed cell death protein 1 (PD-1) blockade with chemotherapy confers significant survival benefit co...
A multicenter pilot study of afatinib re-challenge in patients with <i>EGFR</i> -mutated non-squamous non–small cell lung cancer previously treated with osimertinib.
e20748 Background: Osimertinib (+ chemotherapy) is the standard first-line treatment for EGFR...
Comprehensive genomic profiling to identify molecular determinants of efficacy of IDH1 inhibition in intrahepatic cholangiocarcinoma.
4147 Background: Ivosidenib (IVO) in IDH1 -mutant iCCA yields modest mPFS (2.7 m)...
Construction of an in-vitro peritoneal metastasis model and evaluating its feasibility for experimental peritoneal metastasis research.
e15527 Background: Currently, a wide range of therapeutic strategies are studied and developed for the treatment of perito...
Immune effector cell–associated enterocolitis (IEC-EC) incidence and characterization in cilta-cel–treated patients with RRMM in CARTITUDE clinical studies.
7533 Background: Ciltacabtagene autoleucel (cilta-cel) shows benefit for patients (pts) with relapsed/refractory multiple...
Stage-specific associations between clinical, demographic, and treatment factors and long-term survival in ovarian cancer.
e17610 Background: Ovarian cancer remains the deadliest gynecologic malignancy, largely due to advanced-stage presentation...